Fig. 2From: Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMTa RI, b NRM, c LFS, and d OS by GVHD prophylaxis strategyBack to article page